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ABSTRACT 
 
The Role of miR-143 and miR-145 in the Invasion of Glioblastoma. 
 (April 2010) 
 
 
Matthew Keith Ronck 
Department of Agriculture 
Texas A&M University 
 
 
Research Advisor: Dr. L. Gerard Toussaint 
Department of Neuroscience, Texas A&M Health Science Center 
 
 
 
Glioblastoma multiforme (GBM) is the most common and most malignant type of  
primary brain tumor. It is highly invasive and therefore difficult to treat. The life  
expectancy of patients harboring GBM  is around 12-18 months, even in the best clinical 
trials. GBM invasion prevents a surgical cure; by the time the diagnosis is made, tumor  
cells have invaded normal tissue remote from the tumor mass. Small noncoding RNAs  
may contribute to the invasive phenotype of GBM. MicroRNAs (miRNAs) are small, 
single stranded noncoding regulatory RNA molecules that function to modulate the  
activity of specific mRNA targets and play important roles in a wide range of  
physiological and pathological processes. A previously established in vitro method was  
used to create GBM sub-populations with enhanced invasion (IM3 subpopulations).  
Comparison of micro-RNA expression profiles between GBM parental cell lines and  
IM3 sub-populations revealed differentially expressed miRNAs between the two cell  
 
lines. Two of these miRNAs, miR-143 and mIR-145 were found to be largely over- 
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expressed in the IM3 subpopulations and may serve as potential mediators of the  
invasive phenotype. Knockdown of these miRNAs in U87 cell lines showed an alteration  
in GBM invasion. These miRNAs may serve as therapeutic targets that decrease 
tumor invasion. 
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NOMENCLATURE 
 
 
FBS    Fetal Bovine Serum 
FITC    Fluorescein isothiocyanate 
GBM    Glioblastoma 
IM3    Invaded through Matrigel® three times 
LNA    Locked nucleic acid 
miRNA   Micro-RNA 
RNA                    Ribonucleic acid 
siRNA     Small interfering RNA 
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CHAPTER I 
 
INTRODUCTION 
 
Glioblastoma (GBM) is the most common and most invasive type of primary brain  
tumor. It affects patients of all ages, but accounts for 56% of all brain tumors from ages  
0-14. This tumor has proved incredibly difficult to treat. Several treatment modalities  
include complete surgical resection, external beam radiation, and aggressive  
chemotherapy (Giese et al., 2003); all have proven palliative, resulting in a dismal  
survival rate.  
 
MicroRNAs (miRNAs) are a newly recognized class of micromolecules whose role in  
the body has only recently begun to be studied and understood. miRNAs are short (18-22  
nucleotides), noncoding, single-stranded RNA molecules that function to down-regulate  
gene expression post-transcriptionally by binding to the 3’ untranslated regions of target  
mRNAs. In the last several years, it has been shown that miRNA expression is  
frequently disregulated in cancer. For example, some miRNAs have been shown to up or  
down regulate different proteins central to the cell cycle, permitting tumorigenesis.  
Several miRNAs are over or under-expressed in glioma cells, affecting a wide range of  
processes including cellular proliferation, angiogenesis, differentiation,invasion, and  
 
 
_________________ 
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apoptosis (Silber et al., 2009). For example, a major miRNA regulator of glioma, miR-                               
21, has been shown to target a number of pathways leading to tumorigenesis, including  
components of the p53, TGF-beta, and mitochondrial apoptosis tumor-suppressor  
pathways. It has even been shown to promote chemotherapy resistance  
(Papagiannakopoulos et al., 2008). Additionally, miR-21 promotes invasion in  
glioma cells by downregulating matrix metalloproteinase inhibitors, leading to invasion  
of glioma cells (Gabriely et al., 2008). miR-143 and miR-145, the subjects of this  
experiment, have already been linked to tumor invasion. miR-143 has been identified as  
a mediator of hepatocarcinoma metastases by repressing fibronectin expression (Zhang  
et al., 2009), and both miR-143 and miR-145 are thought to play a large role in  
colorectal cancers (Wang, et al. 2009). Despite all of this, a knowledge gap exists in  
regard to miRNA regulation of GBM invasion. Little is known about the mechanisms of  
how this tumor produces such highly invasive cells. miRNAs could be key contributors  
to the overall invasive phenotype of GBM cells.  
 
In order to determine which miRNAs serve as regulatory elements in GBM invasion,  
highly invasive GBM subpopulations were produced via serial selection through a  
simple, previously established in vitro method (Toussaint et al., 2007) utilizing a Boyden  
Chamber (see Figure 1). The Boyden Chamber consists of an upper and lower chamber  
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Figure 1: Boyden Chamber Invasion Assay. U87 and U87IM3 cells are pipetted into the upper chamber 
and left alone for a set amount of time. In order to invade into the lower chamber, cells must chew through 
a Matrigel® membrane and squeeze through microscopic, 8um pores. After 21 hours, only cells on the 
lower, outer face of the well are counted.  
 
 
which are separated by a plastic wall with numerous, randomly distributed 8um pores. 
Matrigel®, a gelatinous protein material that is secreted by rat sarcoma cells, coats the  
horizontal dividing wall of the chamber. In this case, Matrigel® is used as a rough in  
vitro approximation of brain tissue. This substance is coated along the upper dividing  
wall of the chamber and allowed to settle into the 8um pores. GBM cells are seeded at a  
specific density in the upper chamber, and FBS (Fetal Bovine Serum) is placed in the  
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lower chamber. FBS acts as a chemoattractant for the GBM cells. In order for invasion  
into the lower chamber to occur, highly invasive cells must chew up the Matrigel® and  
squeeze through these microscopic holes, leaving cells that are less invasive in the upper  
chamber. After a set amount of time, these highly invasive cells are harvested and  
collected from the bottom chamber and are hence called the IM cell lines (Invaded  
through Matrigel®). Invasive subpopulations that have invaded through Matrigel® three  
times are thus called IM3 subpopulations and are considered to be unique  
subpopulations of a highly invasive nature. These IM3 subpopulations are used as a  
basis for comparison against parental (normal GBM) cell lines for subsequent siRNA  
knockdown experiments. This IM3 cell selection was a previously established method  
(Toussaint et al., 2007).  
 
RNA profiling data was generated and compared between the parental and the IM3  
subpopulations for three GBM cell lines, U87, U373, and U251. Based on this data, a list  
was generated of potential miRNA targets that regulate GBM invasion (see Figure 2). Of  
these, miR-143 and miR-145 were shown not only to be largely upregulated in the IM3  
cell type of all cell lines, but their graphs were closely similar in shape and amplitude,  
suggesting a similar regulatory mechanism driving the expression of both. This led to the  
hypothesis that these two specific miRNAs play a large regulatory role in GBM  
invasion.  
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Figure 2: Selection of miRNA Candidates. miRNA analysis of three human GBM cell lines revealed 
many over and under-expressed miRNAs between the parental and highly invasive subpopulations. Small 
fraction was not included because that fraction is apt to produce errors with smaller RNAs. These 38 
candidates are ones that express a fold change >2 between the two cell lines. Note that a fold change of  >1 
correlates to miRNAs that were overexpressed in the IM3 subpopulations. Of these candidates, miRNA-
143 and miRNA-145 showed the greatest unidirectional, positive fold change in all cell lines (arrows in 
figure).   
 
 
Antagomirs (siRNA) are short RNA sequences that are closely or exactly  
complementary in sequence to specific miRNA targets. Antagomirs can be transfected  
into cells in order to act via a pathway call RNA silencing. In this pathway, antagomirs  
bind a specific miRNA in the cell, leading to its destruction or inhibition. This, in turn,  
prevents the miRNA from inhibiting mRNA expression. In this experiment, knockdowns  
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were performed on both parental and IM3 cell lines using specific antagomirs of  
miRNA-143 and miRNA-145 (anti-miR-143 and anti-miR-145, respectively), which  
bind to and individually inhibit miR-143 and miR-145 miRNA function. Several  
different combinations of knockdown experiments were performed using these  
antagomirs. IM3 cells and parental GBM cells were transfected with knockdown probes,  
run in a Boyden Chamber assay against a parallel control, and compared against each  
other via total cell counts. 
 
Attachment is a characteristic frequently altered in tumor cells. In order for cells to  
invade through to the lower chamber, they must first attach to the Matrigel® membrane.  
It is important to be able to rule out any major alterations in attachment ability caused by  
the antagomir knockdowns because alterations in attachment can give skewed invasion  
results. In order to account for this, knockdown antagomir-transfected cells were run  
through attachment assays to illustrate any alteration of cellular attachment ability. 
 
 miR-143 & miR-145 knockdown in U87 and U87IM3 cell lines showed an alteration of  
the invasive phenotype in GBM cell lines, suggesting that these miRNAs do in fact play  
a regulatory role in GBM invasion. 
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CHAPTER II  
MATERIALS AND METHODS 
 
Cell lines and culture conditions 
Human U87 (glioma), U251 (glioma), and U373 (astrocytic tumor) cell lines were  
obtained from the American Type Culture Collection (Manassas, VA.). Cells were  
grown in DMEM (Cellgro Media Tech) with 10% FBS, penicillin (10 IU/mL), and  
streptomycin (10 ug/mL) in a humidified 37˚C chamber with 5% CO2.  
 
RNA isolation 
 
Total cellular RNA was extracted using the mirVana miRNA Isolation kit (Ambion) per  
manufacturer’s instructions for total RNA isolation. RNA was analyzed by miRCURY™  
LNA Array microRNA Profiling Services.   
  
 
Anti-miRNA transfection of U87 & U87IM3 
U87 and U87 IM3 cells were transfected with either FITC-labeled anti-miR-143, anti- 
miR-145, or a control LNA knockdown probe which binds nothing in the cell (Exiqon,  
Vedbaek, Denmark) at final concentration of 50nM using Lipofectamine 2000 per  
manufacturer’s instructions (Invitrogen, Carlsbad, CA). Culture medium was changed 8  
hours after transfection and replaced with Optimem medium (Invitrogen Carlsbad, CA)  
for overnight recovery. Efficiency of transfection was assessed using fluorescence  
microscopy. 
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Attachment assay of U87 and U87IM3 cell lines transfected with anti-miR-143 and  
anti-miR-145  
Wells of 24-well tissue culture plate were coated with Matrigel® Basement Membrane  
Matrix (BD Biosciences) diluted with DMEM (1:10) and allowed to sit for 2 hours at  
room temperature, after which unbound Matrigel® was aspirated. U87 and U87IM3  
cells (each twice transfected separately with anti-miR-143 and anti-miR-145) in DMEM  
with 10%FBS were plated at 20,000 cells/mL into wells and incubated at 37˚C for 4  
hours. Wells were gently washed with PBS and the remaining attached cells were fixed  
in 4% paraformaldehyde and stained with hematoxylin for 2 minutes. Wells were  
washed with PBS and cells were counted. 
  
Boyden chamber invasion assay of U87 & U87IM3 cell lines transfected  
with knockdown anti-miRNA 
U87 and U87IM3 cells at 300,000 cells/mL in 0.5mL DMEM (without FBS) were plated  
in the Matrigel®-coated upper chamber of an insert (24-well insert, pore size 8um, BD  
Biosciences). DMEM with 10% FBS located in the lower chamber served as the  
chemoattractant. Cells were allowed to invade for 21 hours at 37˚C, after which time  
cells on the top inner face of the wells were vigorously scrubbed off and cells remaining  
on the bottom layer that migrated through the Matrigel® were fixed in 4%  
paraformaldehyde, stained with hematoxylin, and counted.  
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Statistical analysis 
Data are presented as mean +/- standard deviation. For parental and IM-3 comparisons, a  
t-test was used to determine statistical significance. A t-test with a value of P < 0.05 was  
considered significant. 
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CHAPTER III 
RESULTS 
 
Selection of miRNA candidates yielded two key miRNAs of interest: miR-143 & miR- 
145. These miRNAs were both overexpressed in the highly invasive subpopulations of  
all GBM cell lines, indicating a possible contribution to the invasive phenotype of  
glioblastoma. Not only were the fold changes all in the same direction, but it was noticed  
(from Figure 2) that the ratios of expression levels between the two miRNAs are very  
similar, which suggests a common regulatory pathway. Total RNA isolation, rather than  
a size-fractionation protocol, was used to generate the substrate for expression analysis. 
 
Commercially available antagomirs were used for miR-143 and miR-145 (anti-miR-143  
& anti-miR-145) knockdown. These locked nucleic acid molecules (LNA) are resistant  
to RNAses, and are tagged with a FITC label, which allows visualization under green  
fluorescence microscopy. Transfection of these antagomirs into GBM cells was verified  
using this form of microscopy. U87 and U87IM3 cells were each transfected separately  
with miR-143 and miR-145 for a total of four individual transfections (see Table 1). 
 
 
 
 
 
    11 
 
Table 1: Transfection table.  
 U87  U87IM3 
miR-143 U87 w/anti-miR-143 U87IM3 w/anti-miR-143 
miR-145 U87 w/anti-miR-145 U87IM3 w/anti-miR-145 
 
Cells transfected with specific antagomirs were each run individually through a Boyden  
Chamber Invasion Assay. After a 21-hour invasion time, only cells that invaded through  
 
 
 
 
 
Figure 3: Invasion Assay Cell Counts. Shown are all U87 and U87-IM3 cell counts after invasion assays 
with cells containing knockdown probes miR-143 and miR-145. Knockdowns were run in parallel against 
cells transfected with a control “scramble” probe, which is a probe of a specific sequence that does not 
bind to anything in the cell, and thus, should have no effect on cell migration.  
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the Matrigel® and the 8um pores were counted (Figure 3). Four invasion assays were  
performed, one for each of the four transfections listed in Table 1. Knockdown of miR- 
145 was shown to result in decreased invasion, while knockdown of miR-143 actually  
increased tumor invasion. Between the two subpopulations, counts revealed that  
knockdown with anti-miR-145 averaged a 45% decrease in overall cell invasion while  
knockdown using anti-miR-143 averaged a 44% increase. Resulting cell counts were  
analyzed statistically and compared using a statistical t-test. 
 
Figure 4: Attachment Assay Cell Counts. These are control assays used to account for altered 
attachment ability of GBM cells due to antagomir knockdown. They show that, overall, these antagomir 
probes exert their effects primarily on the invasive abilities of cells, and do not contribute in large part to 
extracellular attachment. 
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The attachment assays did not reveal any statistically significant alterations of  
attachment ability (Figure 4).  
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CHAPTER IV 
SUMMARY AND DISCUSSION 
 
The Matrigel®-filled Boyden Chamber allows the creation of an environment similar to 
the brain tissue in which GBM resides. We can utilize this environment to perform  
representative experiments that we could not normally do in human patients. While this  
setup does allow experimentation in regards to tumor invasion, it also allows the  
conduction of studies relating to tumor cell attachment, another commonly disregulated 
feature of cancer.  
 
The attachment assays were an important addition to this experiment because attachment 
ability can act to mask invasive ability. Differences in attachment to Matrigel® can give 
one cell line a starting advantage over another when comparing their relative ability to 
invade through this matrix of proteins. Therefore, it is important to be able to rule out 
alteration of cellular attachment ability as a contributing factor of invasion. Although 
there were minor differences in the attachment ability of cell lines treated with antagomir 
knockdown, these differences were not statistically significant, nor did they account for 
the differences in cell invasion that we noticed.  
 
In regards to the invasion experiments (Figure 3), the results from the miR-145  
knockdown were the most promising. Invasion of these cells was reduced by almost half  
in the parental and IM3 cell lines. However, knockdown of miR-143 yielded different  
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results. Although the knockdown of the parental cells showed a decrease in invasion, the 
IM3 knockdowns of miR-143 actually yielded an increase in tumor invasion. This is  
confounding because both miR-143 and miR-145 seem to exhibit the same pattern of up- 
regulation across all cell lines (from data from the RNA isolation experiment). Thus, if  
miR-145 knockdown decreased invasion, it would be expected that miR-143 knockdown  
would do the same. This is evidently not the case. One possible explanation for this  
occurrence could be that these two miRNAs act along the same pathway, and their full  
function is only observed when the two are allowed to interact at the same time. In these  
experiments, knockdowns were performed in mutual exclusion by altering expression of  
only one miRNA at a time. A logical future experiment would include a double- 
knockdown of miR-143 and miR-145 at the same time. If a large overall decrease was  
observed, this would be strongly indicative that these two miRNAs do in fact act along a  
common pathway.      
 
Although miR-143 knockdown was not beneficial towards decreasing tumor invasion, 
the sizeable reduction of invasion in the knockdown of miR-145 does indicate that miR- 
145 is a key regulator of the highly invasive phenotype of GBM. Concluding this  
experiment, future plans include in vivo experiments to support the hypothesis that miR- 
145, perhaps in combination with miR-143, plays a significant role in GBM tumor  
invasion. Eventually, it is hoped that, through testing, a treatment for human  
patients with GBM can be developed. While this form of treatment may not be a panacea  
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for GBM, it may help to slow down tumor invasion and increase life expectancy.     
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